Can a Keto Diet Treat Schizophrenia? A Harvard Psychiatrist Weighs In

A Harvard psychiatrist has spoken out about the potential—and limitations—of the ketogenic diet in treating severe mental illness. Dr. Christopher M. Palmer clarified that while some patients have seen symptom remission under strict supervision, claims of a 'cure' for schizophrenia are unfounded and misleading. His comments follow public statements by Robert F. Kennedy Jr. suggesting the diet could cure the disorder.

Dr. Palmer first explored the keto diet as a weight-loss tool for a patient with schizoaffective disorder. After two months, the patient reported fewer hallucinations and delusions, sparking further investigation. In 2019, he documented two schizophrenia cases where patients achieved full remission and stopped antipsychotic drugs, though such outcomes remain rare.

The approach has drawn scepticism from the wider psychiatric community. The American Psychiatric Association views dietary treatment for psychosis as controversial, citing weak evidence and practical challenges, particularly for severely ill individuals. Dr. Paul S. Appelbaum, a leading psychiatrist, called the current data 'very, very preliminary' and urged more rigorous research. No randomised controlled trials on keto diets for schizophrenia are underway or planned globally.

Despite growing interest, Dr. Palmer warns against abandoning conventional treatments. He receives thousands of patient enquiries but stresses that the diet requires close medical oversight due to risks, including potential harm to heart health. While it is an established therapy for epilepsy and weight management, its role in psychiatry remains unproven.

Dr. Palmer envisions dietary therapy as a possible first-line option in the future. For now, he insists antipsychotic medications should not be discontinued without professional guidance.

The keto diet's use in schizophrenia remains experimental, with only isolated cases showing benefit under supervision. Major psychiatric bodies highlight the lack of strong evidence and the difficulties of implementation. Dr. Palmer continues to study the approach but cautions that claims of a cure are premature and potentially dangerous for patients.